Leydig

When a multibillion-dollar brand becomes so toxic that comedians joke that “The Botulism Company” or “International Body Odor” would be more appropriate names, serious work needs to be done to rehabilitate that brand. Leydig was charged with that task when a global financial services company needed to rebrand a business unit. Read more

When an international biopharmaceutical company sought to enter the market for a series of biosimilars of commercially available biologics, they selected Leydig for their expertise to avoid drawn-out litigation and to speed the release of multibillion-dollar biosimilars. Read more